Fortuner rams into electric pole: 2 die on spot; 6 others injured

Bengaluru, Jun 11: Within hours after claiming that it has decided to prohibit schools from schools from conducting online classes till Class 7, the Karnataka government has taken a U-turn and said that currently than ban is only till Class 5.

“Karnataka Govt has decided to stop all online classes for LKG, UKG & classes up to 5th std. To extend this up to 7th std is only a suggestion from few cabinet ministers as expressed in an informal discussion and NOT a decision,” tweeted Prime and Secondary Minister Suresh Kumar.

Law Minister J C Madhuswamy earlier today had stated that the decision to ban online classes till 7th standard was taken by the government.  "All of us were of the opinion that there were challenges faced by students studying in rural areas. Hence, we urged the government to extend the ban on online classes till 7 standard," he said

Hubballi, Jan 6: Elected representatives of the BJP, Congress and JD(S) on Sunday decided to sink their differences and fight unitedly for Karnataka’s rightful share in the Mahadayi and Kalasa-Banduri water dispute with Goa.

The meeting convened by JD(S) MLC Basavaraj Horatti here saw participation of BJP ministers Prahlad Joshi and Jagadish Shettar, Congress and JD(S) lawmakers, among others.

After a 70-minute closed door meeting, MLC Horatti told reporters that they discussed the water dispute in detail and decided to take steps based on inputs from legal and technical experts on the rightful apportioning of water. “Today, we took the first big step towards the overall development of the region, unencumbered by political divisions,” he said.

Though the air was filled with a sense of jubilation as the issue had united seemingly hostile political parties on one side, a few activists expressed disappointment that the meeting failed to set a timeline to resolve the dispute.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.